FDA Approves 2nd Alzheimera[euro](tm)s Drug, Despite Safety Concerns.(lecanemab)

Press/Media

Period	6 Jan 2023

Media coverage

Title	FDA Approves 2nd Alzheimera[euro](tm)s Drug, Despite Safety Concerns.(lecanemab)
Media name/outlet	Consumer Health News
Country/Territory	United States
Date	6/01/23
URL	ct.moreover.com/?a=49747272335&p=1gw&v=1&x=kibEFXMi8IUXowVUyuDSoA
Persons	Howard Fillit